Universities › Queen Mary University of London
MSc Biomedical Engineering (conversion)
Queen Mary University of London — London, United Kingdom
MSc Biomedical Engineering (conversion) is a postgraduate Engineering course at Queen Mary University of London, London, United Kingdom. It takes 1 year, costs £33,150 per year and starts in September.
Postgraduate · 1 year · Full-time · Engineering · £33,150 per year
Intakes: September
Discover QMUL's Conversion MSc in Biomedical Engineering. Designed for graduates from non-engineering backgrounds, this course combines engineering principles with medical science to tackle healthcare challenges. Gain practical skills through hands-on projects and research, preparing for a career in medical technology and innovation.
Modules
- Three compulsory modules, plus a required non-credit bearing module
- Three elective modules
- Research project
- You will undertake self-directed work in completing your extended research project.
- Image based techniques used to determine activation of cancer associated fibroblasts.
- Accelerated wear protocols for understanding clinical wear in modern hip prostheses.
Frequently asked questions
How long is MSc Biomedical Engineering (conversion) at Queen Mary University of London?
MSc Biomedical Engineering (conversion) takes 1 year (Full-time).
How much does MSc Biomedical Engineering (conversion) at Queen Mary University of London cost?
The listed tuition fee is £33,150 per year. Fees can change, so confirm the current amount before you apply.
When does MSc Biomedical Engineering (conversion) start?
Intakes: September.
What level is MSc Biomedical Engineering (conversion)?
It is a postgraduate course in Engineering.
What will I study on MSc Biomedical Engineering (conversion)?
Modules include Three compulsory modules, plus a required non-credit bearing module, Three elective modules, Research project, You will undertake self-directed work in completing your extended research project., Image based techniques used to determine activation of cancer associated fibroblasts. and Accelerated wear protocols for understanding clinical wear in modern hip prostheses..